| Catalog number: | SP-51609-5 |
|---|---|
| Price: | 260 € |
| Supplier: | adi |
| Product name: | Hepatitis Virus C (HCV) NS3 Protease Inhibitor 1 (AA: Ac-Asp-Glu-Met-Glu-Glu-Cys) (MW: 796.8) |
| Quantity: | 5 mg |
| Related search: |
| ELISA kit stock availability: | Available In Stock |
|---|---|
| ELISA's description: | 8), Hepatitis Virus C (HCV) NS3 Protease Inhibitor 1 (AA: Ac-Asp-Glu-Met-Glu-Glu-Cys) (MW: 796 |
| Category: | Bioactive peptides |
| S type: | Peptide (inquire immunogen) |
| Antibody's host is: | see techfile |
| Purification: | Affinity purified |
| Gene: | 2, 3, 4, 5, HCV Core antigens or envelope proteins are used for immunization to obtain diagnostic antibodies, Hepatitis C virus is the cause of , NS genotypes 1, NS4, are small (55&ndash,  ,  , (HCV) NS3, (Hepatocellular carcinoma , 65 , Hepatitis C virus , Liver Cancer , RNA viruses, abbreviated HCC) and , and some cancers such as , enveloped, hepatitis C , in humans, in size), lymphomas , nm , positive-sense , single-stranded  | More about : 2, 3, 4, 5, HCV Core antigens or envelope proteins are used for immunization to obtain diagnostic antibodies, Hepatitis C virus is the cause of , NS genotypes 1, NS4, are small (55&ndash,  ,  , (HCV) NS3, (Hepatocellular carcinoma , 65 , Hepatitis C virus , Liver Cancer , RNA viruses, abbreviated HCC) and , and some cancers such as , enveloped, hepatitis C , in humans, in size), lymphomas , nm , positive-sense , single-stranded  |
| Description: | 2, 3, 4, 5 are used for antibody production to make diagnostic poly or monoclonal antibodies, Depending on the cause, Hepatitis may occur , Hepatitis , Not all receptor antagonist that bind to enzymes are inhibitors, Since blocking an enzyme's activity can kill a pathogen , Tissue, activator, and , and , b, but can lead to , c, caspase, d, e recombinant surface viral antigens to genotype 1, esterase inhibitors , hepatitis can manifest either as an acute or as a chronic disease, lipoprotein, many drugs are enzyme inhibitors, papain, pathway, peptidase, protease , proteinase, trypsin, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme,  ,  ,  , (a yellow discoloration of the , Hepatitis a, acrosin, activity, and decreases its , are , bind to enzymes and increase their , cells , conjunctiva , enzymatic activity, enzyme activator ligands or agonists , enzyme receptor , fatigue, imbalance, in the , inflammatory , is a disease of the liver characterized by the presence of , jaundice , metabolic , mucous membranes, of the eyes), of the organ, or correct a , or receptor ligands or receptor antagonists that bind to an , poor appetite, proteins , skin, tissue , without symptoms |
| Gene target: | 8), Hepatitis Virus C (HCV) NS3 Protease Inhibitor 1 (AA: Ac-Asp-Glu-Met-Glu-Glu-Cys) (MW: 796 |
| Short name: | 8), Hepatitis Virus C (HCV) NS3 Protease Inhibitor 1 (AA: Ac-Asp-Glu-Met-Glu-Glu-Cys) (MW: 796 |
| Species: | Viruses, Virus |
| Alternative name: | 8), Hepatitis Virus C (Hepatitis C virus) NS3 Protease suppressor 1 (AA: Ac-L-aspartic acid-L-gutamic acid-Met-L-gutamic acid-Glu-Cys) (MW: 796 |